Loading organizations...
§ Private Profile · Mountain View, CA, USA
Bioresorbable scaffold technology for treating peripheral arterial disease.
R3 Vascular has raised $104.8M across 2 funding rounds.
R3 Vascular has raised $104.8M in total across 2 funding rounds.
R3 Vascular has raised $104.8M across 2 funding rounds. Most recently, it raised $87.0M Series B in May 2024.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| May 20, 2024 | $87M Series B | Mike Hurley, MD, MS | 415 Capital | Announced |
| Oct 8, 2020 | $17.8M Venture Round | 415 Capital | HBM Medfocus, Wexford Capital | Announced |
R3 Vascular has raised $104.8M in total across 2 funding rounds.
R3 Vascular's investors include Mike Hurley, MD, MS, 415 Capital, HBM-MedFocus, Wexford Capital.